trastuzumab deruxtecan in metastatic her2 breast cancer
Published 1 year ago • 523 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
5:55
decision-making in metastatic her2 breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
0:59
trastuzumab deruxtecan in patients with breast cancer with brain metastases
-
2:37
remarkable data: trastuzumab deruxtecan for her2 bc
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
1:39
treatment for her2 metastatic breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
2:08
recent progress in managing brain metastasis in breast cancer
-
1:15
evaluating trastuzumab deruxtecan in earlier lines of breast cancer therapy
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
0:59
the significance of her2 expression for the activity of trastuzumab deruxtecan
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
1:36
is her2-low a distinct subtype of breast cancer?